Boussard & Gavaudan Investment Management’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-76,852	Closed	-$221	–	147
2021 Q3	$221	Sell	76,852 -23,148	-23%	-$48.4K	0.02%	101
2021 Q2	$271K	Sell	100,000 -43,330	-30%	-$94.4K	0.03%	68
2021 Q1	$388K	Sell	143,330 -156,670	-52%	-$573K	0.04%	70
2020 Q4	$657K	Hold	300,000	–	–	0.09%	43
2020 Q3	$309K	Hold	300,000	–	–	0.04%	47
2020 Q2	$270	Hold	300,000	–	–	0.05%	35
2020 Q1	$219K	Buy	+300,000	New	+$280K	0.05%	28

Other funds holding SRTAW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Boussard & Gavaudan Investment Management's SRTAW Position: Q4 2021 in Review

Boussard & Gavaudan Investment Management sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q4 2021, closing a stake of 76,852 shares — an estimated $221 sold.

Boussard & Gavaudan Investment Management first reported a position in SRTAW in Q1 2020 and held it in 7 quarters. The position peaked at $657K in Q4 2020. 15 funds tracked by Wall St. Rank hold SRTAW as of Q4 2021.

Boussard & Gavaudan Investment Management reported no remaining Strata Critical Medical Inc Warrants position as of Q4 2021 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 76,852 Strata Critical Medical Inc Warrants shares in Q4 2021, an estimated $221.
Boussard & Gavaudan Investment Management first reported a position in Strata Critical Medical Inc Warrants in Q1 2020 and held it in 7 quarters.
Boussard & Gavaudan Investment Management's Strata Critical Medical Inc Warrants position peaked at $657K in Q4 2020.
15 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q4 2021.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.